GMS Ventures & Investments 13D and 13G filings for Outlook Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-12-29 4:43 pm Purchase | 2022-12-28 | 13D | Outlook Therapeutics, Inc. OTLK | GMS Ventures & Investments | 3,563,876 27.900% | 711,521 (+24.95%) | Filing |
| 2022-07-07 5:20 pm Purchase | 2022-07-05 | 13D | Outlook Therapeutics, Inc. OTLK | GMS Ventures & Investments | 2,852,355 25.100% | 2,852,355 (New Position) | Filing |